Advertisement
Screener

InspireMD, Inc. (NSPR) Cost, Direct Material

2.8 / 5 stars · 68/120 Roast Me

InspireMD, Inc. Cost, Direct Material

InspireMD, Inc. (NSPR) reported Cost, Direct Material of $1.63 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:CostDirectMaterial · last filed 2026-08-14

  • InspireMD, Inc. cost, direct material for the quarter ending 2026-06-30 was $1.63M, a 43.32% increase year-over-year.
  • InspireMD, Inc. cost, direct material for the quarter ending 2026-03-31 was $1.69M, a 64.98% increase year-over-year.
  • InspireMD, Inc. cost, direct material for the quarter ending 2025-12-31 was $1.65M, a 24.23% increase year-over-year.
  • InspireMD, Inc. cost, direct material for the quarter ending 2025-09-30 was $1.39M, a 15.05% increase year-over-year.
  • InspireMD, Inc. cost, direct material for fiscal 2025 was $5.20M, a 10.69% increase from fiscal 2024.
  • InspireMD, Inc. cost, direct material for fiscal 2024 was $4.70M, a 23.40% increase from fiscal 2023.
  • InspireMD, Inc. cost, direct material for fiscal 2023 was $3.81M.
Period endCost, Direct Material 3 monthCost, Direct Material 6 monthCost, Direct Material 9 monthCost, Direct Material 12 month
2026-06-30$1.63M
10-Q · filed 2026-08-14
$3.32M
10-Q · filed 2026-08-14
$4.97M
derived: sum of 3 quarters · filed 2026-08-14
$6.36M
derived: sum of 4 quarters · filed 2026-08-14
2026-03-31$1.69M
10-Q · filed 2026-05-07
$3.34M
derived: sum of 2 quarters · filed 2026-05-07
$4.73M
derived: sum of 3 quarters · filed 2026-05-07
$5.87M
derived: sum of 4 quarters · filed 2026-08-14
2025-12-31$1.65M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18
$3.04M
derived: sum of 2 quarters · filed 2026-03-18
$4.17M
derived: sum of 3 quarters · filed 2026-08-14
$5.20M
10-K · filed 2026-03-18
2025-09-30$1.39M
10-Q · filed 2025-11-10
$2.53M
derived: sum of 2 quarters · filed 2026-08-14
$3.55M
10-Q · filed 2025-11-10
$4.88M
derived: sum of 4 quarters · filed 2026-08-14
2025-06-30$1.14M
10-Q · filed 2026-08-14
$2.16M
10-Q · filed 2026-08-14
$3.49M
derived: sum of 3 quarters · filed 2026-08-14
$4.70M
derived: sum of 4 quarters · filed 2026-08-14
2025-03-31$1.02M
10-Q · filed 2026-05-07
$2.35M
derived: sum of 2 quarters · filed 2026-05-07
$3.56M
derived: sum of 3 quarters · filed 2026-05-07
$4.75M
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31$1.32M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18
$2.53M
derived: sum of 2 quarters · filed 2026-03-18
$3.73M
derived: sum of 3 quarters · filed 2026-03-18
$4.70M
10-K · filed 2026-03-18
2024-09-30$1.21M
10-Q · filed 2025-11-10
$2.40M
derived: sum of 2 quarters · filed 2025-11-10
$3.37M
10-Q · filed 2025-11-10
2024-06-30$1.19M
10-Q · filed 2025-08-04
$2.16M
10-Q · filed 2025-08-04
2024-03-31$974.00K
10-Q · filed 2025-05-08
2023-12-31$3.81M
10-K · filed 2025-03-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
PAVmed Inc. (PAVM)United States$0.031B-3.00
Glucotrack, Inc. (GCTK)United States$0.027B
ACCURAY INC (ARAY)United States$0.027B-0.63
SANUWAVE Health, Inc. (SNWV)United States$0.041B5.47
HeartBeam, Inc. (BEAT)United States$0.022B-2.08
RETRACTABLE TECHNOLOGIES INC (RVP)United States$0.021B-6.44
FEMASYS INC (FEMY)United States$0.020B-1.07
NEPHROS INC (NEPH)United States$0.046B23.02
Modular Medical, Inc. (MODD)United States$0.018B-0.88
Sensus Healthcare, Inc. (SRTS)United States$0.048B-3.24